Portugal
Oncological medicines take more than two and a half years to reach the patient
Publication: PÚBLICO
Author: publico@publico.pt
Source published: 29/09/2026, 11:19:46 UTC
Briefing created: 30/09/2026, 01:18:11 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 29/09/2026, 12:35:25 UTC.
Briefings
A Portuguese healthcare system faces a critical shortage of oncological medications, with new treatments taking over 926 days to reach patients. Despite 61% of available stock, half of the inventory has already ruptured, and psychological support is lacking. This situation highlights systemic delays in drug distribution despite high availability rates.
Key points
- New oncological medications in Portugal require 926 days to reach patients, representing a severe distribution delay.
- Although 61% of stock is available, 50% of the inventory has already ruptured, and psychological support is unavailable.
Context and limitations
Data reflects a snapshot from September 2026; specific patient counts, exact rupture dates, and psychological support details are not provided.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 30/09/2026, 01:18:11 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeihrvw3raxrehvajut3d6mdnbqboxegl472gje2giuds67h4nccpmu